Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Labor Union Urges Starbucks Walkout on Thursday
Labor Union Urges Starbucks Walkout on Thursday
Home Depot Beats Q3 Profit, Revenue Estimates
Home Depot Beats Q3 Profit, Revenue Estimates
IEA Raises Outlooks for 2023, 2024 Oil Demand Growth
IEA Raises Outlooks for 2023, 2024 Oil Demand Growth
UBS Predicted Federal Reserve Will Lower Interest Rates in 2024
UBS Predicted Federal Reserve Will Lower Interest Rates in 2024
Consumer Prices Unchanged in October From September
Consumer Prices Unchanged in October From September
Some Companies Rolling Back Self-Checkouts
Some companies are starting to dial back the once-popular self-checkout option.
CDC Warns of High Levels of Lead in Some Applesauce Products
The Centers for Disease Control and Prevention published an official health advisory warning healthcare providers to keep a lookout for children with possible lead poisoning from certain applesauce products.
Stellantis Offering Buyouts to Over 6K Non-Union Workers
Stellantis said it will offer buyouts to about half of its salaried workforce in the U.S.
Stocks Jump After Latest Inflation Data
Stocks jumped after the latest consumer price index report showed inflation cooled last month.
